Survival benefit of direct-acting antiviral agents on HCV-related HCC

被引：0
|
作者：
Chang, Shao-Hsuan [1 ]
Cabrera, Roniel [2 ]
Wilson, Debbie [1 ]
Park, Haesuk [1 ]
Park, Chanhyun [3 ]
机构：
[1] Univ Florida, Pharmaceut Outcomes & Policy, Coll Pharm, Gainesville, FL USA
[2] Univ Florida, Div Gastroenterol Hepatol & Nutr, Coll Med, Gainesville, FL USA
[3] Univ Texas Austin, Hlth Outcomes Div, Coll Pharm, Austin, TX USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1279
引用
收藏
页码：604 / 604
页数：1
相关论文
共 50 条
  • [1] Effect of HCV clearance with direct-acting antiviral agents on HCC
    Josep M. Llovet
    Augusto Villanueva
    Nature Reviews Gastroenterology & Hepatology, 2016, 13 : 561 - 562
  • [2] Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
    Amr Shaaban Hanafy
    Mohamed A. Bassiony
    Mohammad Abd Alkhalik Basha
    Hepatology International, 2019, 13 : 165 - 172
  • [3] Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
    Hanafy, Amr Shaaban
    Bassiony, Mohamed A.
    Basha, Mohammad Abd Alkhalik
    HEPATOLOGY INTERNATIONAL, 2019, 13 (02) : 165 - 172
  • [4] LIVER CANCER Effect of HCV clearance with direct-acting antiviral agents on HCC
    Llovet, Josep M.
    Villanueva, Augusto
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2016, 13 (10) : 561 - +
  • [5] Direct-acting antiviral agents for the treatment of HCV
    Thompson, Alexander J.
    Locarnini, Stephen
    ANTIVIRAL THERAPY, 2012, 17 (06) : 1105 - 1107
  • [6] Direct-acting Antiviral Agents for HCV Infection
    Premkumar, Madhumita
    Dhiman, Radha K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (01) : 1 - 2
  • [7] RISK OF HEPATOCELLULAR CARCINOMA IN HCV-RELATED CIRRHOSIS TREATED WITH DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
    Kilany, Shimaa
    Gomaa, Asmaa Ibrahim
    Sabry, Alyaa
    Moaz, Inas
    Ezzat, Sameera
    Badra, Gamal Ahmed
    Waked, Imam
    HEPATOLOGY, 2019, 70 : 321A - 322A
  • [8] Incidence and Risk Factors for Hepatocellular Carcinoma in a Brazilian Cohort of HCV-Related Cirrhotic Patients Treated with Direct-Acting Antiviral Agents
    Cheinquer, Hugo
    De Maman, Italo, Jr.
    De Araujo, Alexandre
    Wolff, Fernando
    Coelho-Borges, Silvia
    Kowacs, Julia
    HEPATOLOGY, 2018, 68 : 391A - 391A
  • [9] Direct-acting antiviral treatment for HCV
    Goutzamanis, Stelliana
    Doyle, Joseph
    Thompson, Alexander
    Hellard, Margaret
    Higgs, Peter
    LANCET INFECTIOUS DISEASES, 2016, 16 (12) : 1325 - 1326
  • [10] Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
    Kinoshita, Mizuki Nishibatake
    Minami, Tatsuya
    Tateishi, Ryosuke
    Wake, Taijiro
    Nakagomi, Ryo
    Fujiwara, Naoto
    Sato, Masaya
    Uchino, Koji
    Enooku, Kenichiro
    Nakagawa, Hayato
    Asaoka, Yoshinari
    Shiina, Shuichiro
    Koike, Kazuhiko
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 78 - 86
12345